Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(5):291; doi:10.1093/jnci/djj100
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Delayed Versus Immediate Prostate Cancer Surgery

Warlick et al. (p. 355) assessed outcome for two groups of patients with small, lower-grade prostate cancer tumors treated with surgical intervention—one group was treated a median of 3 months after diagnosis and the other group a median of 26.5 months after diagnosis. Noncurable prostate cancer was defined as adverse pathology associated with a less than 75% chance of remaining disease-free for 10 years after surgery. After adjusting for age and prostate-specific antigen (PSA) density (i.e., PSA value divided by prostate volume), the risks of developing noncurable cancer associated with delayed and . . . [Full Text of this Article]

Human Papillomavirus and Cervical Adenocarcinoma

Modeling the Angiogenic Switch

Inhibition of Oncogenic RET mutants by BAY 43-9006

Tumor accumulation of Macromolecular Drug Carriers

Meat Consumption and Gastric and Esophageal Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?